KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) Current Taxes (2016 - 2019)

Historic Current Taxes for Bristol Myers Squibb (BMY) over the last 11 years, with Q1 2019 value amounting to $525.0 million.

  • Bristol Myers Squibb's Current Taxes rose 7736.49% to $525.0 million in Q1 2019 from the same period last year, while for Mar 2019 it was $525.0 million, marking a year-over-year increase of 7736.49%. This contributed to the annual value of $398.0 million for FY2018, which is 7229.44% up from last year.
  • According to the latest figures from Q1 2019, Bristol Myers Squibb's Current Taxes is $525.0 million, which was up 7736.49% from $398.0 million recorded in Q4 2018.
  • Over the past 5 years, Bristol Myers Squibb's Current Taxes peaked at $572.0 million during Q4 2015, and registered a low of $98.0 million during Q2 2015.
  • Over the past 5 years, Bristol Myers Squibb's median Current Taxes value was $291.0 million (recorded in 2017), while the average stood at $295.9 million.
  • In the last 5 years, Bristol Myers Squibb's Current Taxes surged by 11832.06% in 2015 and then crashed by 7342.66% in 2016.
  • Bristol Myers Squibb's Current Taxes (Quarter) stood at $572.0 million in 2015, then plummeted by 73.43% to $152.0 million in 2016, then surged by 51.97% to $231.0 million in 2017, then surged by 72.29% to $398.0 million in 2018, then soared by 31.91% to $525.0 million in 2019.
  • Its Current Taxes stands at $525.0 million for Q1 2019, versus $398.0 million for Q4 2018 and $355.0 million for Q3 2018.